Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Neuroblastoma
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
55%
High-risk Neuroblastoma
50%
Immune Monitoring
37%
Natural Killer Cells
36%
Dinutuximab
31%
Immunogenicity
31%
Tumor Cells
30%
T Cells
30%
High-dimensional Flow Cytometry
29%
Adherent Cells
29%
Drug Library Screening
29%
Immune Response
29%
Chronic Graft-versus-host Disease (cGVHD)
28%
Cell Lineage
26%
CD4+ T
26%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
25%
Immune Thrombocytopenia
25%
Lung
25%
Risk Factors
25%
Organoid Co-culture
25%
Personalized Assessment
25%
Idiopathic Pneumonia Syndrome
25%
Dual-center
25%
Alloimmune
25%
Pediatric Tumors
25%
Cell-based
25%
Lineage Switch
25%
Reconstitution
25%
Epigenetic Modulation
25%
Cancer Immunotherapy
25%
Co-culture System
25%
Survival Outcomes
25%
MHC-I
25%
Microplate Format
25%
Staining Method
25%
384-well
25%
Touchless
25%
Regulatory Immune Response
25%
Interleukin-2
25%
Diffuse Intrinsic Pontine Glioma
25%
Tumor Organoids
25%
Antibody Staining
25%
Immune Reconstitution
24%
Histone Deacetylase Inhibitor (HDACi)
20%
Organoids
20%
Bronchiolitis Obliterans Syndrome
20%
Hematopoietic Cell Transplantation
19%
CD4+
19%
Immune Cells
17%
Immunology and Microbiology
Immunotherapy
82%
Hematopoietic Cell
69%
Cell Transplantation
69%
Immune Response
53%
Organoid
39%
Immunogenicity
33%
T-Helper Cell
33%
T Cell
32%
Natural Killer Cell
32%
Tumor Cell
30%
Acute Graft Versus Host Disease
28%
Adherent Cell
28%
Dinutuximab
28%
Cell Lineage
26%
Liquid Chromatography Tandem Mass Spectrometry
25%
Staining
25%
Bronchiolitis
25%
Lung
25%
Autoimmunity
25%
Coculture
25%
Immune Reconstitution
24%
Major Histocompatibility Complex
21%
Immunocompetent Cell
21%
CD4
19%
Histone
17%
In Vitro
14%
Cytotoxicity
14%
Interleukin 2
13%
Cyclophosphamide
12%
Cytokine
11%
Neuroblastoma Cell Line
10%
Neuroblastoma Cell
10%
Overall Survival
10%
Morbidity
9%
Drug Screening
8%
Event Free Survival
8%
Isotretinoin
8%
Blood Plasma
8%
Granulocyte Macrophage Colony-Stimulating Factor
8%
Peptides
8%
CD3 Antigen
7%
Programmed Cell Death
7%
Monoclonal Antibody
6%
Adenoviridae
6%
Leukocyte Count
6%
Lymphocyte Count
6%
Albumin
5%
High Throughput Screening
5%
Cell Suspension
5%
Cell Marker
5%
